MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problem
Pumping Stopped (1503)
|
Patient Problems
Therapeutic Response, Decreased (2271); Sweating (2444)
|
Event Date 07/24/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a foreign healthcare provider (hcp) via a manufacturer's representative regarding a patient who was receiving morphine (10 mg/ml at 5.66 mg/day) via an implantable pump for an unknown indication for use.It was reported a pump alarm occurred and the patient experienced withdrawal symptoms like sweating.A motor stop [stall] was detected by telemetry.The pump was replaced on (b)(6) 2020 and would be returned.The issue had resolved and the patient status was alive - no injury.No falls or emi had occurred.A pump report from (b)(6) 2020 was provided, indicating a motor stall had occurred on (b)(6) 2020 at 18:10, recovered on (b)(6) 2020 at 18:05, another stall occurred on (b)(6) 2020 at 15:11, and a tube set occurred event occurred on (b)(6) 2020 at 15:11.The pump had not recovered, and had been in a state of motor stall for 430 hours and 17 minutes.Further complications were not reported.
|
|
Manufacturer Narrative
|
H3: the returned device was subjected to a series of standard tests that include but is not limited to visual inspection, alarm output, motor function, and dispense testing.Destructive analysis identified residue in the motor gear train and wearing on the upper and lower shafts of gear number one.Medtronic developed a design change to reduce motor shaft wear and received regulatory approval for the change.Medtronic began distributing pumps with this design change in august 2017.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|